You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Immunotechnology

Designed for the
Immunocompromised

Screen and identify high-titer donors

Screen and identify high-titer donors

Hyperimmune donors with high-titer antibodies to select pathogens are identified.

Tailored compositions

Tailored compositions

Tailored plasma pools are derived from a unique blend of normal source plasma and plasma obtained from the selected donors.

Proprietary testing

Proprietary testing

A proprietary microneutralization assay quantitatively measures titer levels of neutralizing RSV antibodies in plasma donor samples.

*The following patents are applied to ASCENIV™ (immune globulin intravenous, human – slra): 9,107,906 composition 9,714,283 use 9,815,886 methods expiration 2035